{"title":"The First Infant Bloodstream Infection Caused by <i>Pantoea dispersa</i> in China: A Case Report and Literature Review.","authors":"Wenwen Yu, Zhaohui Sun, Mengyuan Wang, Zheng Li, Chunyan Zhang, Yanmeng Sun, Shifu Wang","doi":"10.2147/IDR.S496299","DOIUrl":null,"url":null,"abstract":"<p><p><i>Pantoea</i> is a prevalent environmental Gram-negative bacterium comprising over 20 distinct species. It is a facultative anaerobe capable of forming smooth, translucent colonies on culture plates. <i>Pantoea</i> is typically considered a potential pathogen that may cause infections in plants and animals. With the advancement in mass spectrometry and gene sequencing technologies, human infections caused by <i>Pantoea</i> have increasingly been recognized, raising concerns regarding its pathogenicity and nosocomial transmission that clinicians must address. While there are numerous reports documenting <i>P. agglomerans</i> as a cause of human infections in clinical settings, instances of <i>P. dispersa</i> leading to human pathogenesis are comparatively rare, and the clinical manifestations associated with <i>P. dispersa</i> infections remain largely underexplored. We report a case of a 9-month-old female patient from China whose blood cultures indicated positive Gram-negative bacilli. Through MALDI Biotyper and next-generation sequencing techniques, the pathogen was identified as <i>P. dispersa</i>. Clinically, meropenem was administered for treatment, and the patient's condition improved. We hope this article will help clinicians pay more attention to and better understand infant-related bloodstream infections caused by <i>P. dispersa</i>.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"661-667"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11797003/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S496299","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Pantoea is a prevalent environmental Gram-negative bacterium comprising over 20 distinct species. It is a facultative anaerobe capable of forming smooth, translucent colonies on culture plates. Pantoea is typically considered a potential pathogen that may cause infections in plants and animals. With the advancement in mass spectrometry and gene sequencing technologies, human infections caused by Pantoea have increasingly been recognized, raising concerns regarding its pathogenicity and nosocomial transmission that clinicians must address. While there are numerous reports documenting P. agglomerans as a cause of human infections in clinical settings, instances of P. dispersa leading to human pathogenesis are comparatively rare, and the clinical manifestations associated with P. dispersa infections remain largely underexplored. We report a case of a 9-month-old female patient from China whose blood cultures indicated positive Gram-negative bacilli. Through MALDI Biotyper and next-generation sequencing techniques, the pathogen was identified as P. dispersa. Clinically, meropenem was administered for treatment, and the patient's condition improved. We hope this article will help clinicians pay more attention to and better understand infant-related bloodstream infections caused by P. dispersa.
期刊介绍:
About Journal
Editors
Peer Reviewers
Articles
Article Publishing Charges
Aims and Scope
Call For Papers
ISSN: 1178-6973
Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.